Lunch Symposium: New Data, New Directions: Elevating TAVI with SavvyWire® Guidewire
Sunday, October 26 · 12:30 - 1:30 PM PST
Presentation Theater 2 | Hall D | Exhibition Level | Moscone South | Moscone Center
Learning Objectives
Philippe Genereux, MD, FACC
Explore the clinical implications of the new FDA approval for TAVI in asymptomatic severe AS patients.
Ruby Satpathy, MD, FACC, FSCAI
Review the role of LV pacing in modern TAVI and its impact on procedural workflow and safety.
Ravi Ramana, DO, FACC
Discuss the value of invasive hemodynamics during TAVI, with insights from the latest EuroIntervention article.
Rahul P. Sharma, MBBS, FRACP
Evaluate how the SavvyWire enables procedural efficiency by serving as a pacing, pressure, and guidewire platform.
To learn more about the SavvyWire® Guidewire, OptoWire® Guidewire, VASCADE® Closure System and our portfolio of procedure-enabling technologies, visit our website.
© 2025 Haemonetics Corporation. Haemonetics, SavvyWire, OptoWire and VASCADE are trademarks or registered trademarks of Haemonetics Corporation in the U.S., other countries or both. 09.2025 USA. COL-COPY-002562-US (AA)